11 Liraglutide, a modified analogue of human GLP-1, 12 has been reported to protect against NAFLD and non-alcoholic steatohepatitis (NASH) in human and experimental studies 1316 The underlying mechanisms of these benefits may be through multiple modalities, such as reducing hepatic lipid synthesis, 16 limiting hepatic lipotoxicity, 16 alleviating hepatic inflammation, 16 activating mitophagy, 15 etc
A prospective study of micronutrient status in adolescent pregnancy
Thus, the BBB may represent a viable therapeutic target to prevent or attenuate progression of ADRD prior to histopathological, structural, or functional changes in the brain
90 KimS
FYH News Team Subash Kafle Subash Kafle
It works by replacing the thyroid hormone that is normally produced by the body